Belite Bio, Inc (NASDAQ:BLTE) Q3 2025 Earnings Call Transcript November 10, 2025
Belite Bio, Inc misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.53.
Operator: Ladies and gentlemen, thank you for joining us, and welcome to the Belite Bio Third Quarter 2025 Earnings Call. [Operator Instructions]. I will now hand the call over to Julie Fallon. Please go ahead.
Julie Fallon: Good afternoon, everyone. Thank you for joining us. On the call today are Dr. Tom Lin,...
